Literature DB >> 948034

Effect of propranolol on regional myocardial blood flow and oxygen consumption.

D C Warltier, G J Gross, H F Hardman.   

Abstract

The present investigation was designed to determine the effect of propranolol on regional myocardial blood flow and oxygen consumption (MVO2) in the isolated supported dog heart preparation perfused at a constant coronary blood flow. The transmural distribution of blood flow, determined by the radioactive microsphere technique, was expressed as the epicardial/endocardial blood flow ratio (epi/endo). Propranolol (0.5 mg/kg i.v.) produced a significant decrease in heart rate and myocardial contractile force and an increase in coronary artery perfusion pressure due to an increase in coronary vascular resistance. These hemodynamic changes were accompanied by significant decreases in epi/endo (increased endocardial perfusion) and MVO2. Reduction of perfusion pressure to control by a decrease in total coronary blood flow produced no further change in epi/endo or MVO2. However, increasing heart rate to control increased epi/endo to predrug levels. Contractile force and MVO2 remained reduced below control. Norepinephrine infusion (1 mug/min intracoronary) produced a significant increase in heart rate and contractile force and decrease in perfusion pressure. These changes were accompanied by an increase in epi/endo and MVO2. Propranolol (0.5 mg/kg i.v.) abolished the response to norepinephrine. Propranolol may produce beneficial effects in angina pectoris by a decrease in epi/endo (via a reduction in heart rate) and MVO2 and by beta adrenergic blockade of the deleterious effects of catecholamines.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 948034

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Effects of atenolol on regional myocardial blood flow and ST segment elevation in the canine myocardium.

Authors:  A Berdaux; J R Bossier; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  Intrinsic sympathomimetic activity and coronary blood flow.

Authors:  A Berdeaux; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  The cardiodynamic and metabolic effects of carbochromen and propranolol on the isolated dog heart.

Authors:  J Simaan; G Fawaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

4.  Effect of propranolol on enzymatic and histochemical estimates of infarct size in experimental myocardial infarction.

Authors:  G J Jesmok; D C Warltier; G J Gross; H F Hardman
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

5.  Role of propranolol in improvement of the relationship between O2 supply and consumption in an ischemic region of the dog heart.

Authors:  R S Conway; H R Weiss
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

6.  Acute effects of propranolol on the circulation and on oxygen uptake in conscious rats.

Authors:  J M Ledingham; D C Lees
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

7.  Oxyhaemoglobin equilibrium and chronic beta-adrenoceptor blockade in coronary heart disease.

Authors:  H J Jürgensen; P D Wimberley; U Brodthagen
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

Review 8.  Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.

Authors:  W H Frishman; R J Goldberg; P Benfield
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

9.  The effects of glyceryl trinitrate, isosorbide dinitrate and sodium nitroprusside on haemodynamics, coronary blood flow and myocardial oxygen consumption - an experimental study.

Authors:  W Hess; J B Brückner; D Patschke; G Zimmermann
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.